National Wealth Management Group, LLC Acadia Pharmaceuticals Inc Transaction History
National Wealth Management Group, LLC
- $178 Billion
- Q2 2025
A detailed history of National Wealth Management Group, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, National Wealth Management Group, LLC holds 21,733 shares of ACAD stock, worth $455,089. This represents 0.26% of its overall portfolio holdings.
Number of Shares
21,733
Previous 19,746
10.06%
Holding current value
$455,089
Previous $328 Million
42.93%
% of portfolio
0.26%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
350Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$898 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$253 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$188 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$129 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.39B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...